WinstonWınston
Laboratorios Richmond S.A.C.I.F. logo

Laboratorios Richmond S.A.C.I.F.

RICH.BA
38
Drug Manufacturers - Specialty & Generic · Healthcare
Price
1570.00 ARS
+40.00 (+2.61%)
Market Cap
126.78B ARS
Exchange
Buenos Aires Stock Exchange
Winston Score
38
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Jul 26, 2026 · filings through Mar 31, 2026

Laboratorios Richmond is an Argentine pharmaceutical company that makes and sells medicines for people and animals. Its products include branded generic drugs — copies of well-known medicines sold under its own labels — covering areas like cardiology, diabetes, and infectious diseases. The company sells mainly to pharmacies, hospitals, and healthcare distributors across Argentina and other Latin American markets.

Richmond earns money by manufacturing and selling these drugs directly, keeping a strong gross margin above 60% thanks to its own production facilities and established brand recognition in Argentina. The company operates primarily in Argentina, which makes it heavily exposed to that country's economic instability, including high inflation and currency controls that can erode real profits. Its main growth opportunity lies in expanding its product portfolio and increasing exports to neighboring countries, but Argentina's volatile macroeconomic environment remains the single biggest risk to its financial performance.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+273.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

82.5%ownership

Insiders own a meaningful stake in the company

Cash Runway

~4 years

$4.9B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$4.9B cash & investments at current burn rate

Growth context

Laboratorios Richmond S.A.C.I.F. is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 80.7M (2021) → 80.8M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
54.7%
Healthy — 54.7% gross margin
Operating Margin
1.1%
Thin — 1.1% operating margin
ROCE
0.1%
Weak — 0.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+26.6%
Fast-growing sales (26.6% YoY)
EPS YoY
-7.1%
Earnings shrinking (-7.1% YoY)

Slight earnings drop. Typical near a cyclical low.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
20%
Weak — only 20% of profit becomes cash
FCF Margin
-49.6%
Burning cash (-49.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.79
Elevated debt (1.79)
Interest Cover
1.58x
Dangerous — barely covers interest (1.6x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
6.8x
Attractive valuation — P/E 6.8

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.08%
Moderate income — 2.08% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial